These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3102441)

  • 1. Medullasin stimulates the maturation of natural killer cells from human large granular lymphocytes.
    Aoki Y
    Jpn J Cancer Res; 1987 Jan; 78(1):74-9. PubMed ID: 3102441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of activation of human natural killer cells by medullasin.
    Aoki Y
    Jpn J Cancer Res; 1986 Oct; 77(10):1018-26. PubMed ID: 2430924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medullasin enhances human natural killer cell activity by a mechanism other than the induction of interferons or interleukin-2.
    Aoki Y; Fukuchi K
    Jpn J Cancer Res; 1987 Jan; 78(1):68-73. PubMed ID: 2434455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of activated killer cells from human lymphocytes by medullasin (a serine protease in bone marrow cells).
    Aoki Y; Hase T; Oshimi K; Suzuki K
    Immunology; 1992 Mar; 75(3):481-7. PubMed ID: 1572695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medullasin enhances human natural killer cell activity.
    Aoki Y; Sumiya M; Oshimi K
    J Clin Invest; 1982 Jun; 69(6):1223-30. PubMed ID: 6177714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medullasin induces activated killer cells from human lymphocytes.
    Aoki Y
    Jpn J Cancer Res; 1988 Jun; 79(6):687-90. PubMed ID: 3137194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
    J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analysis of expanded cells from patients with lymphoproliferative disorders of granular lymphocytes may help to clarify the NK cell differentiation.
    Zambello R; Chisesi T; De Rossi G; Pandolfi F; Trentin L; Vespignani M; Luciani M; Cafaro A; Agostini C; Martelli M
    J Clin Lab Immunol; 1986 Jul; 20(3):107-11. PubMed ID: 3746877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of medullasin in granulocytes in biophylaxis. Elastinolytic activity and the potentiation of cytostatic activity of human monocytes.
    Aoki Y; Fukuchi K; Kimura H; Fukusen N
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():101-5. PubMed ID: 3060133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
    J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subpopulation analysis of human granular lymphocytes: associations with age, gender and cytotoxic activity.
    Tilden AB; Grossi CE; Itoh K; Cloud GA; Dougherty PA; Balch CM
    Nat Immun Cell Growth Regul; 1986; 5(2):90-9. PubMed ID: 3724768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody against a surface antigen shared by human large granular lymphocytes and granulocytes.
    Rumpold H; Kraft D; Obexer G; Böck G; Gebhart W
    J Immunol; 1982 Oct; 129(4):1458-64. PubMed ID: 6180009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
    Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
    J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with non-Hodgkin's lymphoma.
    Metha BA; Advani SH; Nadkarni SJ
    Neoplasma; 1988; 35(1):61-8. PubMed ID: 3352838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokine-activated and natural killer cell activity in human intestinal mucosa.
    Hogan PG; Hapel AJ; Doe WF
    J Immunol; 1985 Sep; 135(3):1731-8. PubMed ID: 3926882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets.
    Lebow LT; Jewett A; Bonavida B
    J Immunol; 1993 Jan; 150(1):320-9. PubMed ID: 8417130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased number of functionally defective large granular lymphocytes in lymphoma patients.
    Muhonen T; Teerenhovi L; Saksela E
    Nat Immun Cell Growth Regul; 1987; 6(2):57-64. PubMed ID: 3600676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of neutral serine proteases in tumor cell lysis by natural killer cells (large granular lymphocytes) and activated macrophages.
    Goldfarb RH
    Semin Thromb Hemost; 1986 Oct; 12(4):308-9. PubMed ID: 3538423
    [No Abstract]   [Full Text] [Related]  

  • 20. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.